STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
STRO SUTRO BIOPHARMA INCORPORATED StockScouter® Report
3
StockScouter® Score
SUTRO BIOPHARMA INCORPORATED, a small cap growth company in the healthcare sector, is expected to perform in line with the market over the next six months with slightly higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The enterprise value-to-sales ratio is much lower than the average for comparably-sized companies in the StockScouter universe. Very Positive
Concerns
- Earnings growth in the past year has decelerated moderately compared to earnings growth in the past three years. Negative
- Short-term relative price momentum exhibits meaningful weakness. Negative
- Executives, board directors or major shareholders have both bought and sold shares recently. Neutral
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, growth stocks will be neutral, and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
A
C
A
A